FutureTech II Acquisition Corp.

FTII · · SIC 2836: Biological Products, (No Diagnostic Substances)
65
SEC Filings
$12.02
Close 2025-09-02

Business Summary

In this Report, references to the Company and to we, us and our refer to FutureTech II Acquisition Corp. Formation. We are a blank check company incorporated in Delaware on August 19, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this annual report as our initial business combination (the Business Combination). A...

Latest Stock Quote

FTII 2025-09-02 $12.02 O:$12.02 H:$12.02 L:$12.02 Vol:0.0M VWAP:$12.02
origin leaf: 4600546dd818e1b9d7c33216bbc2ff361e2e48995cc2e173798d50d37077651d

Next Earnings

Q2 FY2026 — expected 2026-08-15

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-04-092024-12-310001641172-25-003384EDGAR48K words
2024-04-052023-12-310001493152-24-013334EDGAR
2023-03-312022-12-310001493152-23-010345EDGAR
2022-03-312021-12-310001493152-22-008388EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-08-222025-06-300001641172-25-025250EDGAR32K words
2025-05-202025-03-310001641172-25-011790EDGAR
2025-01-282024-09-300001493152-25-004006EDGAR
2024-08-142024-06-300001493152-24-032073EDGAR
2024-05-162024-03-310001493152-24-020090EDGAR
2023-11-162023-09-300001493152-23-041663EDGAR
2023-08-142023-06-300001493152-23-028432EDGAR
2023-05-152023-03-310001493152-23-017290EDGAR
2022-11-142022-09-300001493152-22-032169EDGAR
2022-08-162022-06-300001493152-22-023057EDGAR
2022-05-162022-03-310001493152-22-013970EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-100001493152-26-009455EDGAR5K words
2026-02-190001493152-26-007470EDGAR
2026-01-160001493152-26-002585EDGAR
2025-11-120001493152-25-021600EDGAR
2025-08-180001641172-25-024668EDGAR
2025-08-180001641172-25-024504EDGAR
2025-08-120001641172-25-023249EDGAR
2025-04-110001641172-25-003707EDGAR
2025-03-280001641172-25-001125EDGAR
2025-02-210001493152-25-007856EDGAR

65 total filings indexed. 40 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001889450
TickerFTII
Exchange
SIC2836: Biological Products, (No Diagnostic Substances)

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: bbb240626358e18843edbffaa4d8b689ae17bcbc386aa15f1d9a6ce0329b51c4
parent: cc075ffbe48e3793efacc2395e86b28f7043f552325a4baeae3dbb7987887c3f
content hash: 1affe7d8722a627dc10a20ffef0d2b00479b182e3eb9658001dd32f3b1229756
signed: 2026-06-02T19:01:11.269Z
sources: 16 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf